Cargando…
The value of testing for ATXN2 intermediate repeat expansions in routine clinical practice for amyotrophic lateral sclerosis
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626461/ https://www.ncbi.nlm.nih.gov/pubmed/35864146 http://dx.doi.org/10.1038/s41431-022-01146-2 |
_version_ | 1784822738261639168 |
---|---|
author | Salmon, Kristiana Ross, Jay P. Bertone, Vanessa Gobbo, Maria Anoja, Nancy Karamchandani, Jason Dion, Patrick A. Rouleau, Guy A. Genge, Angela |
author_facet | Salmon, Kristiana Ross, Jay P. Bertone, Vanessa Gobbo, Maria Anoja, Nancy Karamchandani, Jason Dion, Patrick A. Rouleau, Guy A. Genge, Angela |
author_sort | Salmon, Kristiana |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9626461 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-96264612022-11-03 The value of testing for ATXN2 intermediate repeat expansions in routine clinical practice for amyotrophic lateral sclerosis Salmon, Kristiana Ross, Jay P. Bertone, Vanessa Gobbo, Maria Anoja, Nancy Karamchandani, Jason Dion, Patrick A. Rouleau, Guy A. Genge, Angela Eur J Hum Genet Viewpoint Springer International Publishing 2022-07-21 2022-11 /pmc/articles/PMC9626461/ /pubmed/35864146 http://dx.doi.org/10.1038/s41431-022-01146-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Viewpoint Salmon, Kristiana Ross, Jay P. Bertone, Vanessa Gobbo, Maria Anoja, Nancy Karamchandani, Jason Dion, Patrick A. Rouleau, Guy A. Genge, Angela The value of testing for ATXN2 intermediate repeat expansions in routine clinical practice for amyotrophic lateral sclerosis |
title | The value of testing for ATXN2 intermediate repeat expansions in routine clinical practice for amyotrophic lateral sclerosis |
title_full | The value of testing for ATXN2 intermediate repeat expansions in routine clinical practice for amyotrophic lateral sclerosis |
title_fullStr | The value of testing for ATXN2 intermediate repeat expansions in routine clinical practice for amyotrophic lateral sclerosis |
title_full_unstemmed | The value of testing for ATXN2 intermediate repeat expansions in routine clinical practice for amyotrophic lateral sclerosis |
title_short | The value of testing for ATXN2 intermediate repeat expansions in routine clinical practice for amyotrophic lateral sclerosis |
title_sort | value of testing for atxn2 intermediate repeat expansions in routine clinical practice for amyotrophic lateral sclerosis |
topic | Viewpoint |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626461/ https://www.ncbi.nlm.nih.gov/pubmed/35864146 http://dx.doi.org/10.1038/s41431-022-01146-2 |
work_keys_str_mv | AT salmonkristiana thevalueoftestingforatxn2intermediaterepeatexpansionsinroutineclinicalpracticeforamyotrophiclateralsclerosis AT rossjayp thevalueoftestingforatxn2intermediaterepeatexpansionsinroutineclinicalpracticeforamyotrophiclateralsclerosis AT bertonevanessa thevalueoftestingforatxn2intermediaterepeatexpansionsinroutineclinicalpracticeforamyotrophiclateralsclerosis AT gobbomaria thevalueoftestingforatxn2intermediaterepeatexpansionsinroutineclinicalpracticeforamyotrophiclateralsclerosis AT anojanancy thevalueoftestingforatxn2intermediaterepeatexpansionsinroutineclinicalpracticeforamyotrophiclateralsclerosis AT karamchandanijason thevalueoftestingforatxn2intermediaterepeatexpansionsinroutineclinicalpracticeforamyotrophiclateralsclerosis AT dionpatricka thevalueoftestingforatxn2intermediaterepeatexpansionsinroutineclinicalpracticeforamyotrophiclateralsclerosis AT rouleauguya thevalueoftestingforatxn2intermediaterepeatexpansionsinroutineclinicalpracticeforamyotrophiclateralsclerosis AT gengeangela thevalueoftestingforatxn2intermediaterepeatexpansionsinroutineclinicalpracticeforamyotrophiclateralsclerosis AT salmonkristiana valueoftestingforatxn2intermediaterepeatexpansionsinroutineclinicalpracticeforamyotrophiclateralsclerosis AT rossjayp valueoftestingforatxn2intermediaterepeatexpansionsinroutineclinicalpracticeforamyotrophiclateralsclerosis AT bertonevanessa valueoftestingforatxn2intermediaterepeatexpansionsinroutineclinicalpracticeforamyotrophiclateralsclerosis AT gobbomaria valueoftestingforatxn2intermediaterepeatexpansionsinroutineclinicalpracticeforamyotrophiclateralsclerosis AT anojanancy valueoftestingforatxn2intermediaterepeatexpansionsinroutineclinicalpracticeforamyotrophiclateralsclerosis AT karamchandanijason valueoftestingforatxn2intermediaterepeatexpansionsinroutineclinicalpracticeforamyotrophiclateralsclerosis AT dionpatricka valueoftestingforatxn2intermediaterepeatexpansionsinroutineclinicalpracticeforamyotrophiclateralsclerosis AT rouleauguya valueoftestingforatxn2intermediaterepeatexpansionsinroutineclinicalpracticeforamyotrophiclateralsclerosis AT gengeangela valueoftestingforatxn2intermediaterepeatexpansionsinroutineclinicalpracticeforamyotrophiclateralsclerosis |